12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·08/13/2025 17:06:22
Listen to the news
Gainers
- Generation Bio (NASDAQ:GBIO) stock increased by 52.5% to $6.17 during Wednesday's regular session. The market value of their outstanding shares is at $27.1 million. As per the news, the Q2 earnings report came out yesterday.
- Reshape Lifesciences (NASDAQ:RSLS) stock increased by 52.46% to $3.1. The market value of their outstanding shares is at $4.8 million.
- Editas Medicine (NASDAQ:EDIT) shares increased by 34.98% to $3.09. The company's market cap stands at $191.7 million. As per the press release, Q2 earnings came out yesterday.
- Ovid Therapeutics (NASDAQ:OVID) shares moved upwards by 34.05% to $0.73. The company's market cap stands at $38.8 million. As per the press release, Q2 earnings came out today.
- Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 30.41% to $3.9. The company's market cap stands at $18.7 million.
- Arcturus Therapeutics (NASDAQ:ARCT) shares moved upwards by 27.6% to $19.0. The market value of their outstanding shares is at $403.8 million. The company's, Q2 earnings came out 2 days ago.
Losers
- Zevra Therapeutics (NASDAQ:ZVRA) stock fell 22.6% to $9.1 during Wednesday's regular session. The market value of their outstanding shares is at $643.0 million. As per the news, the Q2 earnings report came out yesterday.
- Beyond Air (NASDAQ:XAIR) stock decreased by 21.68% to $2.48. The company's market cap stands at $14.6 million. The company's, Q1 earnings came out yesterday.
- Lixte Biotechnology (NASDAQ:LIXT) stock decreased by 17.94% to $3.98. The company's market cap stands at $14.6 million. As per the press release, Q2 earnings came out 4 days ago.
- TuHURA Biosciences (NASDAQ:HURA) stock decreased by 16.62% to $2.71. The company's market cap stands at $151.2 million.
- Plus Therapeutics (NASDAQ:PSTV) shares fell 15.25% to $0.62. The market value of their outstanding shares is at $37.2 million.
- Journey Medical (NASDAQ:DERM) shares declined by 15.22% to $7.24. The market value of their outstanding shares is at $198.9 million. As per the press release, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.